NCT00400790View on ClinicalTrials.gov

Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane

NACompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Coronary Artery BypassDeliriumDementiaAmnesiaCognition DisordersMorbidity
Interventions
DRUG

propofol

Propofol used as the primary anaesthetic agent

DRUG

desflurane

Desflurane used as the primary anaesthetic

Trial Locations (1)

3050

Royal Melbourne Hospital, Melbourne

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

University of Melbourne

OTHER

NCT00400790 - Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane | Biotech Hunter | Biotech Hunter